Management for atrial arrhythmias in adults with complex congenital heart disease

References

• Smith CA, McCracken C, Thomas AS, et al. Long-term outcomes of tetralogy of Fallot: a study from the pediatric cardiac care consortium. JAMA Cardiol. 2019;4:34–41.
   PubMed Web of Science ®Google Scholar
• Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163–172.
   PubMed Web of Science ®Google Scholar
• Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900.
   PubMed Web of Science ®Google Scholar
• Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679–1686.
   PubMed Web of Science ®Google Scholar
• Khairy P, Aboulhosn J, Broberg CS, et al. Thromboprophylaxis for atrial arrhythmias in congenital heart disease: a multicenter study. Int J Cardiol. 2016;223:729–735.
   PubMed Web of Science ®Google Scholar
• Kaemmerer H, Bauer U, Pensl U, et al. Management of emergencies in adults with congenital cardiac disease. Am J Cardiol. 2008;101:521–525.
   PubMed Web of Science ®Google Scholar
• Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73:1494–1563.
   PubMed Web of Science ®Google Scholar
• Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the heart rhythm society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11:e102–165.
   PubMedGoogle Scholar
• Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008;1:250–257.
   PubMed Web of Science ®Google Scholar
• Combes N, Bartoletti S, Hascoët S, et al. Atrial arrhythmia triggering electromechanical dissociation and ventricular fibrillation in a patient with atrial switch operation. Europace. 2020;22:273.
   PubMed Web of Science ®Google Scholar
• Vos MA, Golitsyn SR, Stangl K, et al. Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation. Heart. 1998;79:568–575.
   PubMed Web of Science ®Google Scholar
• Hoyer AW, Balaji S. The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol PACE. 2007;30:1003–1008.
   PubMed Web of Science ®Google Scholar
• Rao SO, Boramanand NK, Burton DA, et al. Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol. Int J Cardiol. 2009;136:253–257.
   PubMed Web of Science ®Google Scholar
• Fish FA, Gillette PC, Benson DW. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol. 1991;18:356–365.
   PubMed Web of Science ®Google Scholar
• Lafuente-Lafuente C, Valembois L, Bergmann JF, et al, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2015;3. DOI:10.1002/14651858.CD005049.pub4. in: Cochrane Database Syst Rev. 04;9:CD005049. PMID: 25820938.
   Google Scholar
• Thorne SA, Barnes I, Cullinan P, et al. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation. 1999;100:149–154. .
   PubMed Web of Science ®Google Scholar
• Stan MN, Ammash NM, Warnes CA, et al. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease–a cohort study. Int J Cardiol. 2013;167:821–826.
   PubMed Web of Science ®Google Scholar
• Wells R, Khairy P, Harris L, et al. Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin Electrophysiol PACE. 2009;32:1313–1318.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart diseaseThe Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J. 2021;42:563–645.
   PubMed Web of Science ®Google Scholar
• Waldmann V, Amet D, Zhao A, et al. Catheter ablation in adults with congenital heart disease: a 15-year perspective from a tertiary centre. Arch Cardiovasc Dis. 2021;114:455–464.
   PubMedGoogle Scholar
• de Groot Natasja MS, Lukac P, Schalij MJ, et al. Long-term outcome of ablative therapy of post-operative atrial tachyarrhythmias in patients with tetralogy of Fallot: a European multi-centre study. Europace. 2012;14:522–527.
   PubMed Web of Science ®Google Scholar
• Mah DY, Alexander ME, Cecchin F, et al. The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol. 2011;22:1013–1017.
   PubMed Web of Science ®Google Scholar
• Gallotti RG, Madnawat H, Shannon KM, et al. Mechanisms and predictors of recurrent tachycardia after catheter ablation for d-transposition of the great arteries after the Mustard or Senning operation. Heart Rhythm. 2017;14:350–356.
   PubMed Web of Science ®Google Scholar
• Kanter RJ, Papagiannis J, Carboni MP, et al. Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. J Am Coll Cardiol. 2000;35:428–441.
   PubMed Web of Science ®Google Scholar
• Wu J, Deisenhofer I, Ammar S, et al. Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. Europace. 2013;15:886–891.
   PubMed Web of Science ®Google Scholar
• Khairy P, Van Hare GF. Catheter ablation in transposition of the great arteries with mustard or senning baffles. Heart Rhythm. 2009;6:283–289.
   PubMed Web of Science ®Google Scholar
• Moreno J, Franco E, Sánchez I. Macroreentrant atrial tachycardia around the native common atrioventricular valve in a surgically corrected complete atrioventricular septal defect. Europace. 2017;19:1438–1438.
   PubMed Web of Science ®Google Scholar
• Satomi K, Shimizu W, Suyama K, et al. Macroreentrant atrial flutter around a common atrioventricular canal in an infant with complicated congenital heart anomaly. Pacing Clin Electrophysiol. 2002;25:1530–1531.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu W, Zhao A, et al. Macro-reentrant biatrial tachycardia relevant to interatrial septal incisions after mitral valve surgery: electrophysiological characteristics and ablation strategy. Heart Rhythm. 2020;17:2135–2144.
   PubMed Web of Science ®Google Scholar
• de Groot NMS, Lukac P, Blom NA, et al. Long-term outcome of ablative therapy of postoperative supraventricular tachycardias in patients with univentricular heart: a European multicenter study. Circ Arrhythm Electrophysiol. 2009;2:242–248.
   PubMed Web of Science ®Google Scholar
• Collins KK, Love BA, Walsh EP, et al. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000;86:969–974.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Shah N, Matsudaira K, et al. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow “focal” ablation. Circulation. 2001;103:699–709.
   PubMed Web of Science ®Google Scholar
• Waldmann V, Amet D, Ladouceur M, et al. Intra-atrial re-entrant tachycardia around atretic tricuspid annulus. Europace. 2019;21:1889.
   PubMed Web of Science ®Google Scholar
• Moore JP, Shannon KM, Fish FA, et al. Catheter ablation of supraventricular tachyarrhythmia after extracardiac Fontan surgery. Heart Rhythm. 2016;13:1891–1897.
   PubMed Web of Science ®Google Scholar
• Walsh EP. Ebstein’s anomaly of the tricuspid valve: a natural laboratory for re-entrant tachycardias. JACC Clin Electrophysiol. 2018;4:1271–1288.
   PubMedGoogle Scholar
• Hassan A, Tan NY, Aung H, et al. Outcomes of atrial arrhythmia radiofrequency catheter ablation in patients with Ebstein’s anomaly. Europace. 2018;20:535–540.
   PubMed Web of Science ®Google Scholar
• Roten L, Lukac P, Groot DE, et al. Catheter ablation of arrhythmias in ebstein’s anomaly: a multicenter study. J Cardiovasc Electrophysiol. 2011;22:1391–1396.
   PubMed Web of Science ®Google Scholar
• Shivapour JKL, Sherwin ED, Alexander ME, et al. Utility of preoperative electrophysiologic studies in patients with Ebstein’s anomaly undergoing the Cone procedure. Heart Rhythm. 2014;11:182–186.
   PubMed Web of Science ®Google Scholar
• Moore JP, Gallotti RG, Chiriac A, et al. Catheter ablation of supraventricular tachycardia after tricuspid valve surgery in patients with congenital heart disease: a multicenter comparative study. Heart Rhythm. 2020;17:58–65.
   PubMed Web of Science ®Google Scholar
• Kella DK, Yasin OZ, Isath AM, et al. Radiofrequency ablation of the cavotricuspid isthmus for management of atrial flutter in patients with congenital heart disease after tricuspid valve surgery: a single Center experience. Heart Rhythm. 2019;16:1621–1628.
   PubMed Web of Science ®Google Scholar
• Pennoyer J, Bykhovsky M, Sohinki D, et al. Successful catheter ablation of two macro-reentrant atrial tachycardias in a patient with congenitally corrected transposition of the great arteries: a case report. J Innov Card Rhythm Manag. 2020;11:4273–4280.
   PubMedGoogle Scholar
• Tseng W-C, Huang C-N, Chiu S-N, et al. Long-term outcomes of arrhythmia and distinct electrophysiological features in congenitally corrected transposition of the great arteries in an Asian cohort. Am Heart J. 2021;231:73–81.
   PubMed Web of Science ®Google Scholar
• Palma EC, Raiszadeh F. Ablation of peri-“mitral” flutter in a patient with congenitally corrected transposition of great vessels and situs inversus. Pacing Clin Electrophysiol PACE. 2012;35:e94–96.
   PubMed Web of Science ®Google Scholar
• Hu F, Liang E, Zheng L, et al. Successful case of complex atrial flutter occurring in a patient with congenitally corrected transposition of the great arteries, aberrant left atrial appendage, and situs inversus. Int J Arrhythmia. 2019;20:3.
   Google Scholar
• Jiang C-X, Long D-Y, Du X, et al. Atrial tachycardia eliminated at the ventricular side in patients with congenitally corrected transposition of the great arteries: electrophysiological findings and anatomical concerns. Heart Rhythm. 2020;17:1337–1345.
   PubMed Web of Science ®Google Scholar
• Waldmann V, Bessière F, Raimondo C, et al. Atrial flutter catheter ablation in adult congenital heart diseases. Indian Pacing Electrophysiol J. 2021;S0972-6292(21):00089–9.
   Google Scholar
• Laredo M, Waldmann V, Soulat G, et al. Transbaffle/Transconduit puncture using a simple CARTO-guided approach without echocardiography in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2020;31:2049–2060.
   PubMed Web of Science ®Google Scholar
• Roy K, Gomez-Pulido F, Ernst S. Remote magnetic navigation for catheter ablation in patients with congenital heart disease: a review. J Cardiovasc Electrophysiol. 2016;27:S45–S56.
   PubMed Web of Science ®Google Scholar
• Masuda K, Ishizu T, Niwa K, et al. Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias. Int J Cardiol. 2017;234:69–75.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Chockalingam P, Balint OH, et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart Br Cardiol Soc. 2010;96:1223–1226.
   Google Scholar
• Khairy P. Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know. Can J Cardiol. 2019;35:1698–1707.
   PubMed Web of Science ®Google Scholar
• Mongeon F-P, Macle L, Beauchesne LM, et al. Non-vitamin k antagonist oral anticoagulants in adult congenital heart disease. Can J Cardiol. 2019;35:1686–1697.
   PubMed Web of Science ®Google Scholar
• Yang H, Bouma BJ, Dimopoulos K, et al. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. Int J Cardiol. 2020;299:123–130.
   PubMed Web of Science ®Google Scholar
• Yang H, Veldtman GR, Bouma BJ, et al. Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe. Open Heart. 2019;6:e000985.
   PubMed Web of Science ®Google Scholar
• Georgekutty J, Kazerouninia A, Wang Y, et al. Novel oral anticoagulant use in adult Fontan patients: a single center experience. Congenit Heart Dis. 2018;13:541–547.
   PubMed Web of Science ®Google Scholar
• Pinto C, Samuel BP, Ratnasamy C, et al. Thrombosis in Fontan patient on apixaban. Int J Cardiol. 2015;182:66–67.
   PubMed Web of Science ®Google Scholar
• Freisinger E, Gerß J, Makowski L, et al. Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients. Eur Heart J. 2020;41:4168–4177.
   PubMed Web of Science ®Google Scholar
• Waldmann V, Amet D, Zhao A, et al. Catheter ablation of intra-atrial reentrant/focal atrial tachycardia in adult congenital heart disease: value of final programmed atrial stimulation. Heart Rhythm. 2020;17:1953–1959.
   PubMed Web of Science ®Google Scholar
• Verma A, Marrouche NF, Seshadri N, et al. Importance of ablating all potential right atrial flutter circuits in postcardiac surgery patients. J Am Coll Cardiol. 2004;44:409–414.
   PubMed Web of Science ®Google Scholar
• Roca-Luque I, Rivas Gándara N, Dos Subirà L, et al. Intra-atrial re-entrant tachycardia in congenital heart disease: types and relation of isthmus to atrial voltage. Europace. 2018;20:353–361.
   PubMed Web of Science ®Google Scholar
• Aziz Z, Shatz D, Raiman M, et al. Targeted ablation of ventricular tachycardia guided by wavefront discontinuities during sinus rhythm: a new functional substrate mapping strategy. Circulation. 2019;140:1383–1397.
   PubMed Web of Science ®Google Scholar
• Kapel GFL, Sacher F, Dekkers OM, et al. Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot. Eur Heart J. 2017;38:268–276.
   PubMed Web of Science ®Google Scholar
• Labombarda F, Hamilton R, Shohoudi A, et al. Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease. J Am Coll Cardiol. 2017;70:857–865.
   PubMed Web of Science ®Google Scholar
• Griffiths JR, Nussinovitch U, Liang JJ, et al. Catheter ablation for atrial fibrillation in adult congenital heart disease: an international multicenter registry study. Circ Arrhythm Electrophysiol. 2022;15:e010954.
   PubMed Web of Science ®Google Scholar
• Liang JJ, Frankel DS, Parikh V, et al. Safety and outcomes of catheter ablation for atrial fibrillation in adults with congenital heart disease: a multicenter registry study. Heart Rhythm. 2019;16:846–852.
   PubMed Web of Science ®Google Scholar
• Cuculich PS, Schill MR, Kashani R, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377:2325–2336.
   PubMed Web of Science ®Google Scholar
• Gunawardene MA, Schaeffer BN, Jularic M, et al. Pulsed field ablation in patients with complex consecutive atrial tachycardia in conjunction with ultra-high density mapping: proof of concept. J Cardiovasc Electrophysiol. 2022;33:2431–2443.
   PubMed Web of Science ®Google Scholar